Laurus Bio is a subsidiary of Laurus Labs and an integrated research-driven biomanufacturing organization with over 15 years of experience in precision fermentation and recombinant DNA technology. The company specializes in manufacturing animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements that are safe, virus-free, and sustainable. Their products cater to various industries such as Stem Cells and Regenerative Medicine, Vaccines and Biological Drugs, Cultured Meat, and Cell-Culture Media Manufacturing. Additionally, Laurus Bio offers comprehensive fermentation-based product development and manufacturing expertise as a service (CDMO) to novel protein companies and bio-manufacturers, covering clone development, strain engineering, process development, and scale-up to large-scale commercial manufacturing. By harnessing the power of precision fermentation and synthetic biology, the company is contributing to a global shift away from animal-derived products, making medicines and food safer and more sustainable. Founded in 2005, Laurus Bio operates in the Biotechnology and Manufacturing industries. The company's corporate goals are aligned with the broader societal objectives of achieving sustainable economic development. Laurus Bio believes in the principle that "doing well happens by doing good." While specific headquarters location and details about the last investment and investors are not available, the company's commitment to leveraging biotechnology for sustainable and safe product development is evident.
There is no investment information
No recent news or press coverage available for Laurus Bio .